Kalaris Therapeutics, Inc. — DEFA14A Filings
5 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Kalaris Therapeutics, Inc. (KLRS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kalaris Therapeutics, Inc. has filed 5 DEFA14A documents with the SEC since 2018. To view all SEC filings by Kalaris Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
POS AM
POSASR
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001193125-25-153441 | Jul 1, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-24-106981 | Apr 23, 2024 | — |
| DEFA14A | DEFA14A | 0001193125-23-088090 | Mar 31, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-22-097526 | Apr 6, 2022 | — |
| DEFA14A | DEFA14A | 0001193125-21-113165 | Apr 12, 2021 | — |